drugset / Trial / NCT04122287

Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

NCT04122287

Phase 4 Unknown 250 enrolled Shandong University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess and compare the effectiveness of levofloxacin-tetracycline -containing and tinidazole-tetracycline-containing quadruple regimens for the primary treatment of Helicobacter pylori infection in patients allergic to penicillin.

Timeline

Start
2019-11-01
Primary completion
2022-10
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 500 mg Oral
Comparator tinidazole Small molecule 500 mg Oral